Both models can be effective, but they solve for different things. Telehealth programs prioritize convenience and accessibility. In-person programs prioritize continuity of care, clinical depth, and the ability to integrate labs, body composition analysis, and hands-on clinical evaluation. At PEAK, we believe medical weight loss is most effective when it includes face-to-face accountability, real-time adjustments, and a clinical environment that supports long-term behavior change.
Side-by-side comparison
This table summarizes the structural differences. Neither model is universally superior—but they reflect different priorities and trade-offs.
| Telehealth-Only Programs | In-Person Medical Programs | |
|---|---|---|
| Initial evaluation | Online questionnaire + async review | Face-to-face consultation with clinician |
| Follow-up visits | Messaging-based or video calls (often optional) | Scheduled in-clinic visits with consistent provider |
| Labs & diagnostics | Optional; patient arranges independently | Ordered and reviewed in-house; results integrated into care |
| Body composition | Self-reported weight | Styku 3D body scan for accurate tracking |
| Medication delivery | Shipped to home | Dispensed in-clinic or shipped; depends on program |
| Nutrition support | App-based meal plans or generalized guidance | Sessions with registered dietitian (RD) |
| Accountability structure | Self-directed or app-based check-ins | Regular weigh-ins and progress reviews with clinical team |
| Side effect management | Messaging support; dose adjustments via portal | Same-day consultation; in-person dose titration |
| Cost (typical) | monthly subscription-style pricing | plan-dependent monthly pricing |
| Geographic reach | Available nationwide (state restrictions apply) | Local only; requires proximity to clinic |
Note: Costs reflect cash-pay estimates. Many in-person programs accept insurance; most telehealth programs do not.
How telehealth weight loss works
Telehealth weight loss programs emerged in response to access barriers—long wait times, lack of local providers, and the need for a more flexible care model. Most operate on a subscription basis: you complete an online intake form, receive a prescription (if approved), and have medication shipped to your home. Follow-up is typically asynchronous (messaging) or via scheduled video calls.
The convenience is real. You don't drive to a clinic. You don't take time off work. You manage everything from your phone. For patients in rural areas or those with demanding schedules, this model removes logistical barriers that might otherwise prevent them from starting treatment.
What telehealth programs do well
Accessibility. Patients in underserved areas can access GLP-1 medications without traveling hours to see a specialist. This is especially valuable in regions where obesity medicine providers are scarce.
Speed. Many telehealth platforms approve and ship prescriptions within days of sign-up. This rapid onboarding appeals to patients who have been waiting months for in-person appointments.
Lower upfront friction. No need to schedule around clinic hours, arrange childcare, or find your way around unfamiliar medical offices. The entire process happens on your terms, in your home.
Where telehealth models face limitations
Depth of clinical evaluation. Most telehealth platforms rely on self-reported health history. There is no physical exam, no review of current medications in real time, and often no independent verification of comorbidities. This increases the risk of contraindications being missed. To understand what a thorough in-person evaluation looks like, read about what to expect at your first weight loss appointment.
Continuity of care. Many telehealth programs assign you to whichever clinician is available, not the same provider each time. This makes it harder to build a therapeutic relationship or track nuanced changes in your response to treatment.
Limited response to side effects. If you experience nausea, vomiting, or other GLP-1 side effects, telehealth support is typically limited to messaging or a video call. Dose adjustments may take days to coordinate. There's no option for same-day, in-person evaluation. Our GLP-1 side effects guide explains how in-person providers manage these issues in real time.
No integrated diagnostics. Labs, body composition analysis, and metabolic testing are either not offered or require you to coordinate them independently. This makes it harder to track progress beyond the number on your bathroom scale.
Telehealth removes friction—but it also removes the infrastructure that makes medical weight loss work long-term.
For patients in rural areas without access to a local obesity medicine practice, or those with mobility limitations that make regular office visits difficult, telehealth can be a reasonable alternative to no treatment at all.
How in-person programs work
In-person medical weight loss programs are built around regular, face-to-face visits with a consistent clinical team. At PEAK, this means an initial consultation where your clinician conducts a full health evaluation, orders baseline labs, and discusses your goals in depth. Follow-up visits occur every 4–6 weeks, or more frequently if dose adjustments or side effects require it.
These visits are not just weigh-ins. They include body composition analysis (via Styku 3D body scan), review of lab trends, nutrition counseling with a registered dietitian, and medication adjustments based on real-time clinical assessment. If something isn't working, your clinician sees it immediately and adjusts the plan—same visit.
What in-person programs do well
Clinical depth. Your clinician conducts a physical exam, reviews your medications, and evaluates contraindications before prescribing. This reduces the risk of adverse events and ensures treatment is appropriate for your specific situation.
Continuity. You see the same provider each visit. They know your history, your challenges, and your response patterns. This longitudinal relationship allows for more personalized adjustments over time.
Integrated diagnostics. Labs, body composition scans, and metabolic markers are tracked in-house. Your clinician reviews results with you in real time and adjusts your treatment plan based on objective data, not just subjective reports.
Accountability. Scheduled in-person visits create a structured rhythm. You show up, you weigh in, you discuss progress. For many patients, this external accountability is the difference between staying on track and falling off.
Rapid response to side effects. If you're struggling with nausea or other GLP-1 side effects, you can call and be seen same-day or next-day. Your clinician can adjust your dose, provide anti-nausea support, or modify your nutrition plan—immediately.
Where in-person models face limitations
Geographic accessibility. You must live within a reasonable distance of the clinic. For patients in rural areas or those without reliable transportation, this is a real barrier.
Scheduling constraints. In-person visits require time off work, childcare arrangements, and coordination around clinic hours. This can be difficult for patients with inflexible jobs or caregiving responsibilities.
Higher upfront commitment. Telehealth feels low-risk because it's easy to start and easy to stop. In-person programs ask for more—time, planning, and a willingness to show up regularly. For some, that feels like too much before they're ready.
What the research says
There is limited long-term data comparing telehealth-only GLP-1 programs to in-person medical weight loss, largely because telehealth GLP-1 prescribing is a recent phenomenon. However, research on telemedicine for chronic disease management offers relevant insights.
A 2022 systematic review in JAMA Network Open found that telehealth interventions for weight management produced modest weight loss (3–5% of body weight) when combined with behavioral support, but outcomes were highly variable and dropout rates were high—often exceeding 40% by six months.
In contrast, in-person medical weight loss programs that include regular clinician visits, nutrition counseling, and medication management show higher retention rates (60–75% at one year) and greater average weight loss (10–15% of body weight when GLP-1 medications are included).
The key difference appears to be structured accountability. Telehealth relies on patients to self-direct their care. In-person programs build accountability into the structure of treatment.
The convenience of telehealth is undeniable. The question is whether convenience alone is enough to sustain behavior change over months and years.
Who benefits from each model
Telehealth may be a better fit if:
- You live in an area with no local obesity medicine providers.
- You have a highly unpredictable schedule that makes regular clinic visits difficult.
- You're already experienced with self-directed health management and don't need external accountability.
- You're willing to arrange your own labs and body composition tracking independently.
In-person care may be a better fit if:
- You've tried weight loss programs before and found that external accountability helps you stay consistent.
- You value continuity of care and want to build a relationship with your clinician.
- You prefer having labs, nutrition counseling, and medication management integrated into one place.
- You want real-time adjustments when side effects or plateau periods arise.
- You have complex medical history (multiple medications, prior bariatric surgery, hormone conditions) that benefit from hands-on clinical evaluation.
If you're considering medication as part of your plan, our guide on how to choose the right weight loss medication explains the clinical decision framework.
Boxed warning — thyroid C-cell tumors: GLP-1 receptor agonists (semaglutide, tirzepatide, liraglutide) carry an FDA boxed warning for thyroid C-cell tumors observed in rodent studies. They are contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN2). Tell your provider immediately if you notice a lump in your neck, difficulty swallowing, or persistent hoarseness.
